Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (271-280 of 778) with videos related to

Pageof 78
Sort By:
JACC. Cardiovascular Interventions|March 31, 2015
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffoldAndrea Mangiameli, Yohei Ohno, Guilherme F Attizzani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVIManveer Singh, Davide Capodanno, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|April 22, 2022
Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options?Claudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
Expert Opinion on Drug Safety|September 19, 2018
Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery diseaseSara Romano, Sergio Buccheri, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|December 10, 2025
Reply: Unveiling the PRODIGY of P2Y<sub>12</sub> Inhibitor Over Aspirin Monotherapy After Acute Coronary Syndrome and Clarification on Trial Classification in Meta-Analysis of Antiplatelet Monotherapy After ACSClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.
European Heart Journal. Acute Cardiovascular Care|January 5, 2026
Dual Antiplatelet Therapy Escalation and De-escalationAntonio Greco, Giacinto Di Leo, Simone Finocchiaro, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device IterationsDavide Capodanno, Sergio Buccheri, Sara Romano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 5, 2025
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN studyClaudio Laudani, Giovanni Occhipinti, Antonio Greco, et al.
Minerva Cardiology and Angiology|May 28, 2024
Future of factor XI inhibitors in cardiovascular practiceAntonio Greco, Nicola Ammirabile, Davide Landolina, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisationClaudio Laudani, Giovanni Occhipinti, Antonio Greco, et al.
Pageof 78

Showing results (271-280 of 778) with videos related to

Sort By:
Pageof 78
JACC. Cardiovascular Interventions|March 31, 2015
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffoldAndrea Mangiameli, Yohei Ohno, Guilherme F Attizzani, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVIManveer Singh, Davide Capodanno, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|April 22, 2022
Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention: Only These 2 Options?Claudio Laudani, Antonio Greco, Giovanni Occhipinti, et al.
Expert Opinion on Drug Safety|September 19, 2018
Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery diseaseSara Romano, Sergio Buccheri, Roxana Mehran, et al.
JACC. Cardiovascular Interventions|December 10, 2025
Reply: Unveiling the PRODIGY of P2Y<sub>12</sub> Inhibitor Over Aspirin Monotherapy After Acute Coronary Syndrome and Clarification on Trial Classification in Meta-Analysis of Antiplatelet Monotherapy After ACSClaudio Laudani, Daniele Giacoppo, Antonio Greco, et al.
European Heart Journal. Acute Cardiovascular Care|January 5, 2026
Dual Antiplatelet Therapy Escalation and De-escalationAntonio Greco, Giacinto Di Leo, Simone Finocchiaro, et al.
Circulation. Cardiovascular Interventions|January 13, 2018
Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device IterationsDavide Capodanno, Sergio Buccheri, Sara Romano, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 5, 2025
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN studyClaudio Laudani, Giovanni Occhipinti, Antonio Greco, et al.
Minerva Cardiology and Angiology|May 28, 2024
Future of factor XI inhibitors in cardiovascular practiceAntonio Greco, Nicola Ammirabile, Davide Landolina, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisationClaudio Laudani, Giovanni Occhipinti, Antonio Greco, et al.
Pageof 78